Articles tagged "Pancreas transplantation"

2019 American Transplant Congress
Donor-Derived Cell-Free DNA for Surveillance in Simultaneous Pancreas and Kidney Transplant Recipients, Can We Extrapolate from Kidney Transplant Alone?
O. K. Olaitan¹, S. Loeb¹, E. Hetterman², V. Peev¹, S. Saltzberg¹, M. Hertl¹, S. Dholakia²
¹Rush University Medical Center, Chicago, IL, ²CareDx, Brisbane, CA
*Purpose: Assessment and identification of early organ injury in Simultaneous Pancreas and Kidney (SPK) patients has clear clinical utility. This analysis was performed to establish…
2019 American Transplant Congress
Circulating Donor Specific Antibody and Biopsy C4d Positivity in Pancreas Rejection Increase the Probability of Earlier Return to Insulin after Rejection
S. M. Riad¹, S. Jackson², E. B. Finger³, R. Kandaswamy³
¹Medicine, University of Minnesota, Minneapolis, MN, ²Complex Care Analytics, Fairview Health Services, Minneapolis, MN, ³Surgery, University of Minnesota, Minneapolis, MN
*Purpose: Outcome data following rejection in pancreas recipients are sparse. We sought to study the influence of C4d positivity and the presence of circulating DSA…
2019 American Transplant Congress
Comparison of Portal vs Systemic Venous Drained Pancreas Transplantation Alone Matched by Propensity Score Analysis
F. Vistoli, N. Napoli, F. Palumbo, E. Kauffmann, V. Perrone, S. Iacopi, C. Lombardo, G. Amorese, P. Marchetti, U. Boggi
Pancreas and Kidney Transplantation Center, University of Pisa, Pisa, Italy
*Purpose: Portal drainage (PD) of pancreas grafts has been associated with improved metabolic profile and fewer rejection episodes than systemic drainage (SD). These advantages would…
2019 American Transplant Congress
Donor Insulin Therapy Predicts Better Graft Survival in Pancreas Transplantation
I. Shapey, A. Summers, H. Khambalia, C. Fullwood, N. Hanley, T. Augustine, M. Rutter, D. van Dellen
University of Manchester, Manchester, United Kingdom
*Purpose: Organ donors frequently develop hyperglycaemia in intensive care, which is managed with insulin. In islet and solid pancreas transplantation (PT) we reported that Donor…
2019 American Transplant Congress
What Are Factors That Can Influence The High Immunological Graft Loss Rate In Young Pancreas Transplant Recipients
A. C. Gruessner, J. Renz, S. Saggi, R. W. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Pancreas transplants (tx) are increasingly performed in older patients with type 1 diabetes mellitus. This trend may be explained by the significantly higher immunologic…
2019 American Transplant Congress
Impact of Simultaneous Pancreas-Kidney Transplantation on Cardiovascular Risk in Type 1 Diabetic Patients
E. Montagud-Marrahi
Servei de Nefrologia i Trasplantament Renal, Hospital Clínic de Barcelona, Barcelona, Spain
*Purpose: Cardiovascular disease is the main cause of death in patients with type 1 diabetes mellitus (DM1). Information available about the impact of simultaneous pancreas-kidney…
2019 American Transplant Congress
Kidney Allograft Survival Among Kidney-pancreas Recipients Compared To Solitary Kidney Recipients: A Mate Analysis Of The Unos/optn Database
O. K. Serrano¹, R. Kandaswamy², E. B. Finger²
¹Hartford Hospital, Hartford, CT, ²Surgery, University of Minnesota, Minneapolis, MN
*Purpose: Deceased donor kidney allocation policies differ between solitary organs and combined transplants. The estimated waiting time for a kidney as part of a simultaneous…
2019 American Transplant Congress
Repeat-Pancreas Transplant after Pancreas Graft Failure in Simultaneous Pancreas and Kidney Transplants is Associated with Better Kidney Graft Survival
S. Parajuli, A. Arunachalam, K. Swanson, F. Aziz, N. Garg, R. Redfield, D. Kaufman, A. Djamali, J. Odorico, D. Mandelbrot
University of Wisconsin, Madison, WI
*Purpose: Simultaneous pancreas and kidney (SPK) transplant is usually the best option for the diabetic ESRD patient. But there is limited information about kidney graft…
2019 American Transplant Congress
Contrast-Enhanced Ultrasonography Predicts Insulin Secretion Ability at 1 Year after Pancreas Transplantation
N. Aida¹, T. Kenmochi¹, T. Ito¹, K. Kurihara¹, A. Kawai¹, T. Nishikawa², I. Hiratsuka³, M. Shibata³, A. Suzuki³, M. Hasegawa⁴, M. Kusaka⁵, M. Hoshinaga⁵
¹Transplantation and Regenerative Medicine, Fujita Health University, Toyoake, Japan, ²Liver, Biliary Tract and Pancreas Diseases, Fujita Health University, Toyoake, Japan, ³Endocrinology and Metabolism, Fujita Health University, Toyoake, Japan, ⁴Nephrology, Fujita Health University, Toyoake, Japan, ⁵Urology, Fujita Health University, Toyoake, Japan
*Purpose: We have previously reported that contrast enhanced ultrasonography (CEUS) is useful to evaluate the graft circulation and to predict the endocrine function of the…
2019 American Transplant Congress
Belatacept Based CNI Free Immunosuppression in Pancreas Transplantation. Results at 4 Years
J. Chen, J. Fridell, M. Yaqub, T. Taber, D. MIshler, O. Adebiyi, M. Mujtaba, A. Sharfuddin
Indiana University School of Medicine, Indianapolis, IN
*Purpose: CNI based Immunosuppression is a well known risk factor for worsening renal function. We report our experience in converting Pancreas Transplant recipients from tacrolimus…